Showing results (1-10 of 1,266) with videos related to

Sort By:
Pageof 127
Innere Medizin (Heidelberg, Germany)|June 30, 2025
[CAR T cells in non-malignant diseases]Fabian Müller, Melanie Hagen, Georg Schett, et al.
Lancet (London, England)|September 25, 2023
CAR T-cell therapy in autoimmune diseasesGeorg Schett, Andreas Mackensen, Dimitrios Mougiakakos
Zeitschrift Fur Rheumatologie|May 23, 2024
[CAR T-cell therapy in rheumatology-What we know so far?]Melanie Hagen, Andreas Wirsching, Daniela Bohr, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 19, 2023
CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus ErythematosusJule Taubmann, Fabian Müller, Melek Yalcin Mutlu, et al.
The Journal of Rheumatology|September 15, 2025
Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary AnalysisJule Taubmann, Melanie Hagen, Fabian Müller, et al.
JCI Insight|May 9, 2024
Selective CAR T cell-mediated B cell depletion suppresses IFN signature in SLEArtur Wilhelm, David Chambers, Fabian Müller, et al.
Molecular Therapy. Methods & Clinical Development|September 25, 2023
Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapyDaniel Nunez, Darshil Patel, Jenell Volkov, et al.
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.
Nature Reviews. Rheumatology|August 6, 2024
Advancements and challenges in CAR T cell therapy in autoimmune diseasesGeorg Schett, Fabian Müller, Jule Taubmann, et al.
Bioconjugate Chemistry|April 1, 2021
Triton X-114 and Amine-Based Wash Strategy Reduces Lipopolysaccharides to FDA Limit and Achieves Purer, More Potent Recombinant ImmunotoxinRebekka George, Franziska Gsottberger, Anna Ammon, et al.
Pageof 127